Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1978 1
1982 1
1983 1
1984 3
1985 2
1986 1
1987 2
1990 1
1991 3
1992 4
1993 1
1994 1
1995 2
1996 4
1997 3
1998 6
1999 13
2000 7
2001 16
2002 22
2003 30
2004 43
2005 40
2006 52
2007 61
2008 36
2009 46
2010 39
2011 47
2012 42
2013 55
2014 64
2015 84
2016 56
2017 74
2018 65
2019 80
2020 112
2021 112
2022 113
2023 92
2024 92
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,371 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma.
van der Heijden MS, Sonpavde G, Powles T, Necchi A, Burotto M, Schenker M, Sade JP, Bamias A, Beuzeboc P, Bedke J, Oldenburg J, Chatta G, Ürün Y, Ye D, He Z, Valderrama BP, Ku JH, Tomita Y, Filian J, Wang L, Purcea D, Patel MY, Nasroulah F, Galsky MD; CheckMate 901 Trial Investigators. van der Heijden MS, et al. Among authors: ku jh. N Engl J Med. 2023 Nov 9;389(19):1778-1789. doi: 10.1056/NEJMoa2309863. Epub 2023 Oct 22. N Engl J Med. 2023. PMID: 37870949 Clinical Trial.
Methylation-specific PCR.
Ku JL, Jeon YK, Park JG. Ku JL, et al. Methods Mol Biol. 2011;791:23-32. doi: 10.1007/978-1-61779-316-5_3. Methods Mol Biol. 2011. PMID: 21913069
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma.
Loriot Y, Matsubara N, Park SH, Huddart RA, Burgess EF, Houede N, Banek S, Guadalupi V, Ku JH, Valderrama BP, Tran B, Triantos S, Kean Y, Akapame S, Deprince K, Mukhopadhyay S, Stone NL, Siefker-Radtke AO; THOR Cohort 1 Investigators. Loriot Y, et al. Among authors: ku jh. N Engl J Med. 2023 Nov 23;389(21):1961-1971. doi: 10.1056/NEJMoa2308849. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870920 Clinical Trial.
Gasdermin D drives focal crystalline thrombotic microangiopathy by accelerating immunothrombosis and necroinflammation.
Watanabe-Kusunoki K, Li C, Bandeira Honda TS, Zhao D, Kusunoki Y, Ku J, Long H, Klaus M, Han C, Braun A, Mammadova-Bach E, Linkermann A, Van Avondt K, Richter M, Soehnlein O, Linder MI, Klein C, Steiger S, Anders HJ. Watanabe-Kusunoki K, et al. Among authors: ku j. Blood. 2024 Jul 18;144(3):308-322. doi: 10.1182/blood.2023021949. Blood. 2024. PMID: 38657197
A dietary commensal microbe enhances antitumor immunity by activating tumor macrophages to sequester iron.
Sharma G, Sharma A, Kim I, Cha DG, Kim S, Park ES, Noh JG, Lee J, Ku JH, Choi YH, Kong J, Lee H, Ko H, Lee J, Notaro A, Hong SH, Rhee JH, Kim SG, De Castro C, Molinaro A, Shin K, Kim S, Kim JK, Rudra D, Im SH. Sharma G, et al. Among authors: ku jh. Nat Immunol. 2024 May;25(5):790-801. doi: 10.1038/s41590-024-01816-x. Epub 2024 Apr 25. Nat Immunol. 2024. PMID: 38664585
Guided bone regeneration.
Kim YK, Ku JK. Kim YK, et al. Among authors: ku jk. J Korean Assoc Oral Maxillofac Surg. 2020 Oct 31;46(5):361-366. doi: 10.5125/jkaoms.2020.46.5.361. J Korean Assoc Oral Maxillofac Surg. 2020. PMID: 33122463 Free PMC article.
CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancer.
Steinberg GD, Shore ND, Redorta JP, Galsky MD, Bedke J, Ku JH, Kretkowski M, Hu H, Penkov K, Vermette JJ, Tarazi JC, Randall AE, Pierce KJ, Saltzstein D, Powles TB. Steinberg GD, et al. Among authors: ku jh. Future Oncol. 2024 May;20(14):891-901. doi: 10.2217/fon-2023-0271. Epub 2024 Jan 8. Future Oncol. 2024. PMID: 38189180 Free article.
Comprehensive molecular characterization of TFE3-rearranged renal cell carcinoma.
Lee CR, Suh J, Jang D, Jin BY, Cho J, Lee M, Sim H, Kang M, Lee J, Park JH, Lee KH, Hwang GS, Moon KC, Song C, Ku JH, Kwak C, Kim HH, Cho SY, Choi M, Jeong CW. Lee CR, et al. Among authors: ku jh. Exp Mol Med. 2024 Aug;56(8):1807-1815. doi: 10.1038/s12276-024-01291-2. Epub 2024 Aug 1. Exp Mol Med. 2024. PMID: 39085357 Free PMC article.
1,371 results